Spire Wealth Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
DM
Spire Wealth Management's ORGO Position: Q2 2022 in Review
Spire Wealth Management sold out of Organogenesis Holdings (ORGO) in Q2 2022, closing a stake of 24,117 shares — an estimated $184K sold.
Spire Wealth Management first reported a position in ORGO in Q3 2021 and held it in 3 quarters. The position peaked at $184K in Q1 2022. 146 funds tracked by Wall St. Rank hold ORGO as of Q2 2022.
- Spire Wealth Management reported no remaining Organogenesis Holdings position as of Q2 2022 after selling out during the quarter.
- Spire Wealth Management sold 24,117 Organogenesis Holdings shares in Q2 2022, an estimated $184K.
- Spire Wealth Management first reported a position in Organogenesis Holdings in Q3 2021 and held it in 3 quarters.
- Spire Wealth Management's Organogenesis Holdings position peaked at $184K in Q1 2022.
- 146 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2022.
Based on Spire Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.